Bonesupport Holding AB (publ) (STO:BONEX)
Sweden flag Sweden · Delayed Price · Currency is SEK
323.00
+1.60 (0.50%)
Jul 25, 2025, 5:29 PM CET

Bonesupport Holding AB Company Description

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection.

It also offers CERAMENT Bead Tray, an adjunctive local delivery option for surgeons for targeted delivery to osseous defects and for dead space management.

In addition, the company develops preclinical product candidates to promote bone regrowth focusing on trauma, revision arthroplasty, chronic osteomyelitis, and foot and ankle surgery.

Bonesupport Holding AB (publ) was founded in 1999 and is headquartered in Lund, Sweden.

Bonesupport Holding AB (publ)
Bonesupport Holding AB logo
CountrySweden
Founded1999
IndustryMedical Instruments & Supplies
SectorHealthcare
Employees139
CEOEmil Billbäck

Contact Details

Address:
Scheelevägen 19
Lund, 223 70
Sweden
Phone46 4 62 86 53 70
Websitebonesupport.com

Stock Details

Ticker SymbolBONEX
ExchangeNasdaq Stockholm
Fiscal YearJanuary - December
Reporting CurrencySEK
ISIN NumberSE0009858152
SIC Code3842

Key Executives

NamePosition
Emil BillbäckChief Executive Officer
Håkan JohanssonChief Financial Officer
Michael Wrang MortensenExecutive Vice President of Global Research & Development and Operations
Annelie Aava ViknerExecutive Vice President of Global Marketing
Helena L. BrandtExecutive Vice President of Human Resources
Dr. Michael Diefenbeck M.D., Ph.D.Executive Vice President of Medical and Clinical Affairs and Chief Medical Officer
Fergus MacLeodGM and Executive Vice President of Commercial Operations of EUROW
Michael RothGM and Executive Vice President of Commercial Operations of North America
Anna StegmarkExecutive Vice President of Quality Management and Regulatory Affairs